Cargando…
Integrative analysis of gut microbiota and fecal metabolites in metabolic associated fatty liver disease patients
OBJECTIVE: Metabolic associated fatty liver disease (MAFLD) affects nearly a quarter of the world’s population. Our study aimed to characterize the gut microbiome and overall changes in the fecal and serum metabolomes in MAFLD patients. METHODS: Thirty-two patients diagnosed with MAFLD and 30 health...
Autores principales: | Yang, Lidan, Dai, Yuzhao, He, He, Liu, Zhi, Liao, Shenling, Zhang, Yu, Liao, Ga, An, Zhenmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441872/ https://www.ncbi.nlm.nih.gov/pubmed/36071958 http://dx.doi.org/10.3389/fmicb.2022.969757 |
Ejemplares similares
-
Comparison of the diagnostic value between triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio in metabolic-associated fatty liver disease patients: a retrospective cross-sectional study
por: Liu, Zhi, et al.
Publicado: (2022) -
Genetic variants associated with metabolic dysfunction‐associated fatty liver disease in western China
por: Liao, Shenling, et al.
Publicado: (2022) -
Comparison of the Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Metabolic Associated Fatty Liver Disease: Updated Systematic Review and Meta-Analysis
por: Dai, Yuzhao, et al.
Publicado: (2021) -
A nomogram for predicting metabolic steatohepatitis: The combination of NAMPT, RALGDS, GADD45B, FOSL2, RTP3, and RASD1
por: Liao, Shenling, et al.
Publicado: (2021) -
The Microbiota and It’s Correlation With Metabolites in the Gut of Mice With Nonalcoholic Fatty Liver Disease
por: Gu, Congwei, et al.
Publicado: (2022)